Association of increased neopterin production with decreased humoral immunity in the elderly

Experimental Gerontology

Volumn 38, Issue 5, 2003, Pages 583-587

  Murr, Christian ^a   Hainz, Ursula ^b   Asch, Ester ^b   Berger, Peter ^b   Jenewein, Brigitte ^b   Saurwein Teissl, Maria ^b   Grubeck Loebenstein, Beatrix ^b   Fuchs, Dietmar ^a,c  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Aging; Neopterin; Tetanus toxoid antibodies

Indexed keywords

GAMMA INTERFERON; NEOPTERIN; TETANUS ANTIBODY; TETANUS TOXOID;

ADULT; AGE; AGED; AGING; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0037991455     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(03)00062-7     Document Type: Article

References (29)

1. Diamondstone L.S., Tollerud D.J., Fuchs D., Wachter H., Brown L.M., Maloney E., Kurman C.C., Nelson D.L., Blattner W.A. Factors influencing serum neopterin and ß2-microglobulin levels in healthy diverse population. J. Clin. Immunol. 14:1994;368-374.
2. Fahey J.L., Taylor J.M.G., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J.V. The prognostic value of cellular and prognostic markers in infections with human immunodeficiency virus type I infection. N. Engl. J. Med. 322:1990;166-172.
3. Fuchs D., Hausen A., Reibnegger G., Werner E.R., Dierich M.P., Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol. Today. 9:1988;150-155.
4. Fuchs D., Malkovsky M., Reibnegger G., Werner E.R., Forni G., Wachter H. Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol. Lett. 23:1989;103-108.
5. Fuchs D., Shearer G.M., Boswell R.N., Clerici M., Reibnegger G., Werner E.R., Zajac R.A., Wachter H. Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Clin. Exp. Immunol. 80:1990;44-48.
6. Fuchs D., Weiss G., Reibnegger G., Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious and malignant diseases. Crit. Rev. Clin. Lab. Sci. 29:1992;307-341.
7. Fuchs D., Weiss G., Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int. Arch. Allergy Immunol. 101:1993;1-6.
8. Gergen P.J., McQuillan G.M., Kiely M., Ezzati-Rice T.M., Sutter R.W., Virella G. A population-based serologic survey of immunity to tetanus in the United States. N. Engl. J. Med. 23:(332):1995;761-766.
9. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J. Virol. 75:2001;12182-12187.
10. Grubeck-Loebenstein B., Wick G. The aging of the immune system. Adv. Immunol. 80:2002;243-284.
11. Grubeck-Loebenstein B., Berger P., Saurwein-Teissl M., Zisterer K., Wick G. No immunity for the elderly. Nat. Med. 4:1998;870.
12. Hainz U., Aigner K., Asch E., Berger P., Böhmer F., Feldkircher B., Horwath B., Jenewein B., Kassal H., Kistner O., Mack H., Pfeiffer K.-P., Pils K., Plank J., Renner D., Saurwein-Teissl M., Schwanzer E., Trieb K., Grubeck-Loebenstein B. Do recommended vaccination strategies give sufficient protection in the elderly? An Austrian-wide evaluation. Wien. Klin. Wochenschr. 114:2002;187-193.
13. Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser D., Reibnegger G., Swetly P., Troppmair J., Wachter H. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma. J. Exp. Med. 160:1984;310-316.
14. Leblhuber F., Walli J., Demel U., Tilz G.P., Widner B., Fuchs D. Increased serum neopterin concentrations in patients with Alzheimer's disease. Clin. Chem. Lab. Med. 37:1999;429-431.
15. Ledochowski M., Murr C., Widner B., Fuchs D. Association between insulin resistance, body mass and neopterin concentrations. Clin. Chim. Acta. 282:1999;115-123.
16. Ledochowski M., Murr C., Jäger M., Fuchs D. Dehydroepiandrosterone, ageing and immune activation. Exp. Gerontol. 36:2001;1739-1747.
17. Ledochowski M., Murr C., Widner B., Fuchs D. Inverse relationship between neopterin and immunoglobulin E. Clin. Immunol. 98:2001;104-108.
18. Maurer W., Mutz I. Impfempfehlungen des obersten Sanitätsrates. Österr. Ärztezeitung. 13/14:2000;28-37.
19. Mellor A.L., Munn D.H. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu. Rev. Immunol. 18:2000;367-391.
20. Murr C., Bergant A., Widschwendter M., Heim K., Schröcksnadel H., Fuchs D. Neopterin is an independent prognostic variable in females with breast cancer. Clin. Chem. 45:1999;1998-2004.
21. Reibnegger G., Huber L.A., Jürgens G., Schönitzer D., Werner E.R., Wachter H., Wick G., Traill K.N. Approach to define 'normal ageing' in man. immune function, serum lipids, lipoproteins and neopterin levels. Mech. Ageing Dev. 46:1988;67-82.
22. Reibnegger G., Aichberger C., Fuchs D., Hausen A., Spielberger M., Werner E.R., Margreiter R., Wachter H. Posttransplant neopterin excretion in renal allograft recipients: reliable diagnostic aid of acute rejection and predictive marker of long-term survival. Transplantation. 52:1991;58-63.
23. Romagnani S. Human Th1 and Th2: doubt no more. Immunol. Today. 12:1991;256-257.
24. Samsonov M.Y., Tilz G.P., Egorova O., Reibnegger G., Balabanova R.M., Nassonov E.L., Nassonova V.A., Wachter H., Fuchs D. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus. 4:1995;29-32.
25. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., Parson W., Bock G., Schönitzer D., Trannoy E., Grubeck-Loebenstein B. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 168:2002;5893-5899.
26. Steger M.M., Maczek C., Berger P., Grubeck-Loebenstein B. Vaccination against tetanus in the elderly: do recommended vaccination strategies give sufficient protection? Lancet. 348:1996;762.
27. Weiss G., Willeit J., Kiechl S., Fuchs D., Jarosch E., Oberhollenzer F., Reibnegger G., Tilz G.P., Gerstenbrand F., Wachter H. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis. 106:1994;263-271.
28. Weiss G., Murr C., Zoller H., Haun M., Widner B., Ludescher C., Fuchs D. Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin. Exp. Immunol. 116:1999;435-440.
29. Werner E.R., Werner-Felmayer G., Fuchs D., Hausen A., Reibnegger G., Yim J.J., Pfleiderer W., Wachter H. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. J. Biol. Chem. 265:1990;3189-3192.